+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 69Years
All Genders
ID07487623

Study of a Nutritional Supplement With Resveratrol, Quercetin, Taurine, Inulin, and Whey Protein to Improve Liver Health in Adults With Chronic Hepatitis C

Led by University of Guadalajara · Updated on 2026-03-23

26

Participants Needed

2

Research Sites

6 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying whether a nutritional supplement containing resveratrol, quercetin, taurine, inulin, and whey protein can improve biochemical, molecular, and clinical markers in patients with liver disease caused by chronic hepatitis C infection. The trial compares this supplement to whey protein alone to see if the combination offers extra benefits for liver-related health and clinical outcomes. Participants will take either the investigational supplement or the active control whey protein alone daily for 12 weeks. They will attend clinic visits every 4 weeks during this period for laboratory tests and clinical evaluations to monitor progress and effects. During the study, participants will undergo assessments including liver function tests, quality of life questionnaires CLDQ, and frailty evaluations using grip strength, timed chair stands, and balance tests. Researchers will also measure pro-inflammatory cytokines and antioxidant activity. The study aims to collect these data from enrollment through the 12-week treatment period to evaluate the supplements impact.

CONDITIONS

Brief Title

Evaluation of the Hepatoprotective Effects of a Nutritional Supplement in Patients With Liver Disease Secondary to Chronic Hepatitis C Virus Infection (RESQUETI Study).

Research Team

J

Juan Roberto Rodriguez-Echevarria, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here